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Novelty and impact statement: This study examines which sociodemographic information 
population-based cancer registries in India collect and use to make visible how poverty and 
inequality contribute to unequal cancer incidence. Findings show equity analyses of cancer 
incidence data in India are possible as most registries published estimates of cancer outcomes 
disaggregated by age, sex and geography, and several registries collected – but did not report – 
information on education, marital status, mother tongue, religion, income, and occupation.  
 
Abstract 
In India, population-based cancer registries (PBCRs) cover less than 15% of the urban and 1% of 
the rural population. This study examines practices of registration in PBCRs in India to 
understand efforts to include rural populations in registries, and efforts to measure social 
inequalities in cancer incidence. We selected a purposive sample of six PBCRs in Maharashtra, 
Kerala, Punjab and Mizoram and conducted semi-structured interviews with staff to understand 
approaches and challenges to cancer registration, and the sociodemographic information 
collected by PBCRs. We also conducted a review of peer-reviewed literature utilizing data from 
PBCRs in India. Findings show that in a context of poor access to cancer diagnosis and 
treatment, and weak death registration PBCRs have developed additional approaches to cancer 
registration, including conducting village and home visits to interview cancer patients in rural 
areas. Challenges included: PBCR funding and staff retention, abstraction of data in medical 
records, address verification, and responding to cancer stigma and patient migration. Most 
PBCRs published estimates of cancer outcomes disaggregated by age, sex and geography. Data 
on education, marital status, mother tongue and religion were collected, but rarely reported. Two 
PBCRs collected information on income and occupation and none collected information on 
caste. Most peer-reviewed studies using PBCR data did not publish estimates of social 
inequalities in cancer outcomes. Results indicate that collecting and reporting sociodemographic 
data collected by PBCRs is feasible. Improved PBCR coverage and data will enable India’s 
cancer prevention and control programs to be guided by data on cancer inequities. 
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Introduction  
The International Agency for Research on Cancer (IARC) estimates that only 1 in 5 low-and 
middle-income countries (LMICs) have the necessary data to drive cancer policy.1 High quality 
population-based cancer registries (PBCRs) cover 1% of the population in Africa, 4% in Asia, 
and 6% Latin America.2 Yet, more than half of the global cancer burden is in India, Russia and 
China, which include approximately 40% of the world’s population, experience 46% of all new 
cancers worldwide, and account for 52% of cancer deaths globally.3 Recognizing the need to 
address the invisibility of places and populations in cancer statistics and improve cancer 
registries in LMICs,4-7 IARC established the Global Initiative for Cancer Registry Development 
(GICR) in 2011. A technical support hub was created in the Tata Memorial Center (TMC) in 
Mumbai, India to support countries developing or expanding PBCRs in South and East Asia.5  
In a context where cancer registration is expanding in LMICs, this study examines the practices 
of population-based cancer registration in India among six PBCRs to understand approaches to, 
and challenges of, cancer registration, efforts to include rural populations in registries, and 
efforts to measure social inequalities in cancer outcomes. 
India in particular faces unique challenges for cancer registration. Second to China, India has the 
world’s largest population (1.34 billion) which is predominantly rural (66.4%). Access to 
affordable and equitable cancer care is limited8-11 and low death registration coverage (67.40%) 
makes it challenging to estimate cancer mortality (Supplementary Table S1). India’s network of 
PBCRs are estimated to cover less than 15% of the urban population12 and less than 1% of the 
rural population13 pointing to serious deficits in coverage. Important discrepancies exist in 
estimates of both cancer incidence and leading types of cancer, depending on which data are 
employed. For example, IARCs estimate of India’s age-standardized incidence rate (ASR) 
(89.4/100,000)14 is notably lower than that estimated by the by the Global Burden of Disease 
(106.6/100,000).15, 16 Estimates of cancer cases are close to one million, but also differ, with non-
overlapping 95% confidence intervals (Table 1). Moreover, whereas IARC suggests that lip and 
oral cavity, lung, stomach and colorectum are the leading cancer sites for males, GBD suggests 
lip and oral cavity, lung, other pharynx, and prostate cancer. Such inconsistencies raise concerns 
for cancer prevention and control in India and more widely, given that India’s registries are 
relied upon to estimate cancer incidence in other Indian states,17 and across South Asia, including 
in Bangladesh, Bhutan, Nepal, Pakistan and Myanmar (Supplementary Figure S1).2, 14, 18 
Still another challenge in the current estimates of cancer presented in Table 1 is the absence of 
cancer incidence or case counts disaggregated by sociodemographic variables other than age and 
sex raising unanswered questions about how cancer incidence differs by income, ethnicity, 
religion and caste. Such data are crucial for documenting, monitoring, analyzing, and preventing 
cancer inequities,19 which represent suffering and death which is unfair unjust and preventable20-
24 and most often experienced by historically marginalized populations.    
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Sample selection  
At the time of data collection in 2018, the National Cancer Registry Program (NCRP) of the 
Indian Council of Medical Research (ICMR) included 27 PBCRs and 7 hospital-based cancer 
registries (HBCRs).25 At least 17 additional PBCRs had additionally been funded by the 
Department of Atomic Energy (DAE) and established by the Tata Memorial Center (TMC).   
From among the NCRP and TMC registries, we selected a purposive sample of six PBCRs based 
on registry characteristics and discussions with colleagues at TMC and NCRP. To ensure we 
included registries functioning in a range of contexts, we selected: two rural PBCRs in India (in 
Sangrur, Punjab and Barshi, Maharashtra); the oldest PBCR (Mumbai, Maharashtra); the most 
recently formed urban PBCR (Chandigarh); the PBCR reporting the highest burden of cancer in 
India (Aizawl, Mizoram); and, a PBCR serving an urban and rural population 
(Thiruvananthapuram, Kerala).  
Data collection  
We developed a semi-structured interview guide and a registry profile form to understand: the 
characteristics of each registry; the data collection process; which sociodemographic variables 
were collected and reported; the strengths and challenges of cancer registration; and 
recommendations to improve registration.  
The first author traveled to each registry over eight weeks in 2018 to conduct key informant 
interviews. In each registry, 3-7 people were interviewed and included the PI or Co-PI and at 
least one fieldworker. Additional interviews were conducted based on staff availability and the 
division of labor in the registry: these included data managers, social workers, coders, or 
physicians. Interviews were also conducted with other experts in cancer registration who were 
affiliated with these registries, including NCRP. Interviews were audio recorded when possible, 
or notes were taken. We sought and obtained verbal informed consent to name each registry in 
the analysis. 
To gain insight into the use of India’s PCBR data for population health monitoring and research, 
we also examined the most recent report from each registry and searched the Web of Science and 
PubMed for all peer-reviewed articles using the following terms: “population-based cancer 
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registry” or “registr*”, “India”, “cancer” as well as the locations of each registry in the sample. 
All studies that discussed the state of PBCRs in India or used PBCR data were included. For 
these studies, we examined which articles presented estimates of cancer disaggregated by 
sociodemographic variables. Literature reviews, abstracts, letters to the editor, multi-country 
studies, or studies that used data from hospital-based registries or tumor registries were excluded.   
Analysis  
We used the registry profile form and interview guide to develop a codebook and define themes 
for analysis a priori which included: PBCR characteristics; challenges of registration; funders 
and technical assistance; incidence and mortality data collection; reporting; data uses; 
recommendations to improve registration. The following additional themes, which emerged from 
the data, were added during data analysis: history of the PBCR; patient engagement; approach to 
registration; strengths of the PBCR; government schemes; links between hospital and 
population-based registries. Analysis was conducted using NVivo 12. Each registry had an 
opportunity to check if the information in the profile was accurate but did not analyze or interpret 
findings.  
 
Records that met the inclusion criteria of the literature review were categorized into the 
following thematic groups based on a review of the title and abstract: cancer surveillance; time 
trends; projections; case-control or cohort studies; associational studies; costing studies; studies 
about PBCRs in India. For studies that reported data, we conducted full text searches and 
calculated the number and percentage of articles which reported estimates of cancer 
disaggregated by sociodemographic variables.  
Findings  
Context and data collection approaches of six Population Based Cancer Registries 
Six PBCRs were included across four states: Maharashtra, Kerala, Punjab and Mizoram. Four 
were located in large cancer hospitals, the Mumbai PBCR was located in the Indian Cancer 
Society, and the Chandigarh PBCR in the School of Public Health in the Post Graduate Institute 
of Medical Education and Research. Registries were funded and supported by NCRP or TMC. 
Core staff ranged from 7-14 members and included: a program manager, ‘social investigators’ 
(fieldworkers), and a data manager. Each registry worked in a different context of population 
size and density, geography and cancer burden. Table 2 and the additional text in the 
Supplementary Materials describe the context, coverage, registration processes and cancer cases 
in each PBCR. 
Each PBCR used methods of cancer registration recommended by IARC and ICMR and visited 
between 29 and 75 institutions (data sources) for case finding. These included hospitals, 
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pathology and cytology labs, CT scan centers, nursing homes, and the offices coordinating 
enrolment in government schemes for cancer treatment. For mortality data, PBCR staff either 
accessed death registration data online or visited the office of vital statistics, crematoriums and 
burial grounds. However, the history and context of each registry -- population size, density, 
geography and cancer burden -- shaped approaches to case finding (Table 2). For example, the 
PBCR in Mizoram explained, “there are so many cancer patients every day…many homes have 
cancer”, while the Sangrur PBCR underscored the long distances staff traveled to find cancer 
cases: “If you cover…15,000-16,000 households you don't find many symptomatic patients so it's 
very difficult”.  
Notably in Sangrur and Barshi -- PBCRs working in rural areas -- staff routinely visited villages 
and households, and conducted case finding with health workers, and local leaders. Phone calls 
or home visits with patients were not only a way to confirm address and collect data, but offered 
an opportunity for PBCR fieldworkers to build relationships with patients, address stigma, 
encourage treatment, demystify hospital processes, and provide assistance in accessing 
government schemes for cancer. Given its large caseload, the Mumbai PBCR relied solely on 
information in patient records from each data source. Similarly, the Thiruvananthapuram and 
Chandigarh PBCRs relied predominantly on medical records for case finding, but telephoned 
patients to address any incomplete fields in the data collection form. The Aizawl PBCR 
interviewed patients in the hospital in which the registry was located and then relied on phone 
calls, local birth and death registrars and the Young Mizo Association, a state-wide community 
group, to collect additional information.  
[Table 2] 
The distribution and heterogeneity of cancer cases across the data sources PBCR staff relied on 
for case finding reflected the journeys of cancer patients through local health systems, and the 
quality of local and state-level health data. For example, in Mizoram, as one respondent 
explained, PBCR staff found most cancer cases in Aizawl as patients traveled to the state capital 
for diagnosis and treatment: “we don’t have pathology or diagnostics in sub-centers…every 
district has a hospital, but only Lunglei [another district] has a pathologist…so everyone comes 
to Aizawl”. Similarly, in Thiruvananthapuram, because the PBCR was located in the Regional 
Cancer Center (RCC), the vast majority of cases came from here. Cancer cases in Barshi often 
came from cancer detection camps conducted across all 346 villages in the catchment area by the 
PBCR and cancer hospital. For mortality data, the Aizwal, Thiruvananthapuram and Mumbai 
PBCRs benefited from high coverage and quality of death registration, including online access in 
Thiruvananthapuram. In contrast, the registry in Sangrur, Punjab had developed processes to 
check crematoriums, burial grounds and religious sites, review data in the local death registrar’s 
office and to conduct a verbal autopsy with relatives to find and identify cancer deaths.  
Sociodemographic data collected by six Population Based Cancer Registries  
This article is protected by copyright. All rights reserved.
 Page  
All PBCRs published estimates of cancer incidence disaggregated by age and sex and most by 
geography - village, district, urban/rural (Table 3). Although most PBCRs collected information 
on education, marital status, mother tongue and religion, only one PBCR published estimates of 
cancer incidence disaggregated by all these outcomes. Only two PBCRs collected – but did not 
publish – information on income and occupation and no PBCR collected information on 
ethnicity, Scheduled Caste, Scheduled Tribe, or caste. The PBCRs which did not interview 
patients directly were limited to the sociodemographic information available in medical records.  
[Table 3] 
Among registries with direct patient contact, a minority of respondents felt it was easy and 
possible to collect sociodemographic variables while others expressed concern about the 
ramifications of asking about sociodemographic information. Education was considered to be 
easy to ask about. However, in Mizoram, pointing to the lack of variation in education, one 
respondent observed: “it might be possible to look at education and cancer, but Mizoram is the 
second most educated state…so it is not a good criteria”. Income was considered challenging to 
get accurate information about and data on caste – which is not collected – was also perceived as 
challenging: "we can't ask caste…in Punjab the biggest political fights happen over caste, more 
than religion". Contrastingly, in Kerala, religion was considered to be more sensitive. Other 
respondents described how it was possible to ‘figure out’ these variables based on other 
identifiers. For example, the patient’s name, occupation, whether a spouse was listed or not were 
occasionally used to guess religion, mother tongue and marital status. One respondent 
summarized the status quo as: "there are widespread socioeconomic inequalities in cancer...but 
they need to be further documented” and another respondent discussed how controversial it 
might be for government stakeholders if registries published estimates of cancer disaggregated 
by caste.  
Uses of cancer registry data  
There was agreement about the benefit of cancer registries, especially in examining if cancer 
burden, leading sites, and cancer stages were changing. Uses of data within registries included: 
flagging cases to guide follow up with patients and preparing reports that were either issued 
annually or every 2-3 years (Table 2). No individual level or aggregated data outside of the data 
presented in reports were publicly available. Few registries conducted additional or exploratory 
analyses of data. All registries submitted data to NCRP or TMC and most submitted data to 
IARC for inclusion in CI5 and GLOBOCAN 2018.  
When asked about uses of data outside the registry, several respondents discussed answering the 
state government’s questions about cancer burden. In Punjab, registry staff described how the 
2013 report showed cancer in Punjab is: “lower than the national average and now we are trying 
to dispel the myth. People feel like that because they don’t have access to care”. There were very 
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few examples where registry data were used to inform treatment and control programs at the 
local or state level. One example included the introduction of endoscopy centers in response to 
stomach cancer incidence in Mizoram. Respondents agreed that registry data could be better used 
to guide treatment and control programs, and to understand sociodemographic inequalities in 
cancer care and outcomes.  
The review of the literature revealed 230 out of 1290 peer-reviewed articles that were either 
about PBCRs or utilized PBCR data published between 1960 and 2019. Most articles were on 
cancer surveillance or time trends. Among the 188 articles utilizing PBCR data, 70 articles 
(37%) reported estimates of cancer disaggregated by at least one sociodemographic variable 
(Table 4); education, marital status and religion were the most commonly used variables, and 
case control and cohort studies were most likely to present estimates disaggregated by 
sociodemographic variables. However, very few studies that used PBCR data were explicitly 
designed to examine cancer inequities. Supplementary Table S3 lists all the articles that 
presented disaggregated estimates by article category.  
[Table 4] 
Challenges of cancer registration  
The challenges registry staff faced while case finding and collecting data included securing the 
cooperation of data sources, and abstracting information from primarily paper-based medical 
records in hospitals with vastly different record keep systems (Table 5). Most registries cited a 
lack of funding as the primary challenge of operating the registry which affected paying salaries, 
and retaining staff. In registries with direct patient contact, staff described the challenge of 
responding to bad patient experiences in efforts to seek treatment, including long journeys and 
lines, poor medical care, or the loss of a family member. Most registries faced major challenges 
with cancer stigma, however, this was more pronounced in the new registries (Sangrur and 
Chandigarh) where staff explained: “there is low awareness of cancer. We can’t say ‘cancer’ 
directly, we ask: ‘have you had treatment?’ and ‘what did the doctor say?’” In contrast, staff in 
Barshi, discussed the changes in cancer stigma since the 1980s:  
“10-20 years ago, when we went to the house to talk about the symptoms…they would 
look at us with shock as if to say ‘what are you saying?’…. now, they recognize us and 
know what we are going to ask. There is a lot more awareness and now we don’t have 
problems in the villages”.  
[Table 5] 
Recommendations to improve cancer registration and implications for new PBCRs 
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Finally, reflections and recommendations offered by respondents to improve cancer registration 
have implications for the design, and data collection of new PBCRs, including ways to improve 
the collection of sociodemographic data (Table 6). Of note was the emphasis respondents placed 
on the importance of building relationships between PBCR staff and the institutions which 
served as data sources, village health workers and local government. Persevering in efforts to get 
data was another key recommendation as was safely sharing data across registries, including 
hospital-based registries. Respondents advocated for the development of new population-based 
registries in India, particularly in rural areas:  
“In the last 35 years this is the only rural registry...we need more rural registries, 
because our data cannot be used for all of rural India...75% of the population in India is 
rural and most registries are urban.” (Barshi)  
Discussion  
We show that both urban and rural registries in India have developed a range of approaches to 
respond to the challenging environment for population-based cancer registration, and in many 
cases, are engaging in cancer screening, education, and stigma reduction alongside registration.26, 
27 Although some of the challenges registries face are shared by other registries globally4, 7, 11, 28 – 
for example, in negotiating access to data for case finding, ensuring reliable data, and gaining 
adequate resources – the major challenges of registration we report are inseparable from the 
structural and systems level lacunae in the health system in India. Poor and unaffordable access 
to cancer care and diagnosis, weak death registration, and sparse health information systems8-11 
shape which places and populations are included in cancer data, and are implicated in cancer 
inequities in India,4, 10 and globally.29 However, our findings show that PBCRs in India use 
additional methods of case finding and cancer registration in response to the challenging social, 
cultural, and financial realities of cancer care seeking and caregiving. These approaches allow 
data on cancer incidence to be collected in contexts where patients often reach the hospital at 
later cancer stages, struggle financially, migrate for treatment, or seek multiple medical opinions. 
Such approaches to cancer registration could be instructive for efforts to initiate or expand cancer 
registration in other contexts in both high and low-income countries.       
The diverse cancer burden seen across six PBCRs in four states is reflective of the heterogeneity 
in both cancer incidence and the leading sites of cancer across India.9, 15 India’s context where 
each state is the size of some of the world’s most populous countries underscores the importance 
of state-level cancer registry development with a focus on rural areas. In the words of one 
respondent: “the state government needs to do something and focus on high [incidence] cancers. 
Usually they just blame it on tobacco consumption”, which underscores the importance of the 
government delivering its commitments to expanding cancer care infrastructure and improving 
quality of care. We highlight the need to improve the dissemination and use of PBCR data to 
local government to design cancer screening and control programs at the local and state level: 
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such efforts could better realize the sentiment expressed by most respondents that “cancer 
registration is for cancer control...it is not an end in itself”. India’s national program for non-
communicable diseases (NCDs) which launched in 2010 and includes cancer screening, 
prevention and treatment, develops tertiary cancer care facilities, and health systems 
strengthening for NCDs8 could offer an expansion of registration alongside cancer treatment 
facilities. We found there was strong agreement among respondents that expanding cancer 
registration without links to the expansion of cancer treatment facilities was unethical. This 
argument was rooted in concerns about health equity stemming from offering diagnoses to 
patients without ensuring access to treatment.  
A dual commitment to cancer registration and treatment is also relevant for other LMICs 
developing national cancer control plans,30 especially given that in 2017, only 26% of low-
income countries reported pathology services in the public sector, and 30% reported treatment 
services.31 As cancer care expands in LMICs, our findings contribute evidence on the importance 
of ensuring hospital-based and population-based cancer registries are a key component of NCD 
and cancer control plans, and that these registries are able to document and analyze social 
inequities in cancer. Making data on the sociodemographic distribution of cancer visible will be 
essential in both preventing and addressing social inequities across the cancer continuum, and in 
bringing attention to the burden of cancer among populations living in poverty and in rural 
areas.32  
Prior research has documented the critical role of disease surveillance in the development and 
implementation of health policy, including the role of cancer registries in cancer control, 
research, and monitoring.28, 33 In line with this, many respondents articulated the belief that one 
respondent described: “registries are not only a tool for data collection they are for 
action...surveillance means data collection for action”. Our study specifically examines 
sociodemographic data and findings show that, although a wealth of data currently exists in 
PBCRs, these data could be better utilized for research, for advocacy, for guiding and assessing 
cancer prevention, treatment and control, and for measuring social inequities in cancer. First, 
efforts to ensure data quality and completeness of the socidemographic data that are currently 
being collected by PBCRs are essential in enabling the use of sociodemographic data. Secondly, 
in addition to improve data quality, improvements in the utilization of existing PBCR data could 
include conducting analyses of cancer incidence disaggregated by geography, education, 
religion, language or using existing resources - like the US National Cancer Institute’s health 
disparities calculator34 - to estimate the magnitude of inequities. 
Efforts to ensure the routine, and high quality, measurement of key sociodemographic variables 
that are comparable across PBCRs in India will enable comparable cross-sectional and 
longitudinal analyses of social inequalities in cancer incidence in India. Epidemiologic research 
from other countries that utilizes comparable data from multiple PBCRs reveals large social 
inequalities in cancer incidence,35-37 mortality, and survival.38-40 However, many of these 
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analyses rely on linking PBCR data with sociodemographic information and measures of 
deprivation that are not collected by PBCRs. We show that many PBCRs in India are collecting 
these data at the individual level with enormous potential to improve and use these data for 
equity analyses.  
However, as our findings from the review of the literature indicated, limited peer-reviewed 
research has utilized PBCR data to explicitly examine social inequities in cancer, with variables 
such as caste and ethnicity or SC/SCT never considered, and variables like occupation and 
income very occasionally considered – even though several PBCRs reported they were currently 
collecting these data. These results are in line with a 2014 study on cancer research in India 
which showed that cancer genetics and medical oncology (chemotherapy) are the dominant 
forms of cancer research,41 underscoring the need for further research on the role of poverty and 
inequality in shaping population distributions of cancer. Our findings show that while the uses of 
PBCR data may thus far be limited, many PBCRs are collecting sociodemographic data. Further 
research on the completeness and missingness of sociodemographic data in PBCRs will be 
important in improving the quality of these data. Analyses which use PBCR data to estimate 
social inequities in cancer outcomes, or which document efforts to improve registration in rural 
areas, including how cancer registries interact with the health system, are warranted, especially 
given the lack of research on cancer registration in LMICs.7, 42 Our findings also underscore the 
value of engaging PBCR staff to understand the realities of registration practices and further 
examine the institutional efforts to address the challenges of registration we document.43 
In summary, the expansion of cancer registration in India offers opportunities to both include 
rural populations in registries, integrate equity analyses of PBCR data into routine monitoring 
and reporting, and allow new registries to benefit from the lessons and good practices in existing 
registries. Given that many PBCRs in India receive technical assistance from NCRP, TMC and 
IARC, there are opportunities to share best practices between cancer registries as cancer 
registration expands within India.  
To conclude, data collected by PBCRs drives cancer epidemiology research, and can be used to 
develop and target prevention and control programs in India. Efforts by IARC, NCRP, PBCRs, 
policy makers, and state-level governments to improve the quality of sociodemographic data in 
PBCRs could make visible how poverty and inequality contribute to unequal cancer incidence 
and are a crucial step in allowing cancer prevention and control programs to both monitor and 
address social inequalities in cancer.  
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Table 1: GLOBOCAN, GBD and NCRP estimates of cancer incidence in India 
  
GLOBOCAN9 GBD10,11 NCRP17 CI5, Vol XI8 
Year 
 
2018 2016 2012-2014  
Number of PBCRs included 26 42 27 16 
Population Data for denominator and  
age-standardization   








Cancer cases     
 
Estimate 1.16 million 1.07 million No national 
estimates. All 
estimates are 












Uncertainty interval  
(1.15 million - 1.17 million) (1.04 million - 1.10 million) 
Incidence Rate (Combined)    
 
Crude 85.5 81.2 (79.3 - 83.7) 
 
Age standardized  89.4 106.6 (104.2 - 109.7)  
Incidence Rate (Female)    
 
Crude 90.0 87.0 (84.4 - 91.8) 
 
Age standardized  90.0 106.1 (102.9 - 111.8) 
Incidence Rate (Male)   
 
 
Crude 81.3 75.9 (73.2 - 78.0) 
 
Age standardized  89.8 108.6 (105.0 - 111.8) 
Cancers with highest age-standardized incidence rate (ASR)   
 
Female  
ASR (World Standard)  
 
1. Breast (24.7) 
2. Cervix uteri (14.7) 
3. Ovary (5.5) 
4. Lip, oral cavity (5.5) 
ASR (GBD Standard) 
 
1. Breast (21.6) 
2. Cervical (13.5) 
3. Lip and oral cavity (9.2) 
4. Stomach (7.3)  
 
Male 
1. Lip, oral cavity (13.9) 
2. Lung (7.8) 
3. Stomach (6.2) 
4. Colorectum (5.8) 
1. Lip and oral cavity (13.5) 
2. Lung (10.7) 
3. Other pharynx (9.35) 
4. Prostate (9.0) 
Estimates of incidence disaggregated 
by sociodemographics  
Age and Sex  Age and Sex  Age and Sex  Age and Sex  
Table shows the most recent estimates of cancer incidence in India published by GLOBOCAN, Global Burden of Disease (GBD), the National 
Cancer Registration Program (NCRP), and Volume XI of Cancer Incidence in Five Continents (CI5). Supplementary Table S2 lists the registries 
included in each set of estimates.  
 
GLOBOCAN estimates come from GLOBOCAN 2018: National incidence was estimated as follows:  
1. Incidence rates for the North-Eastern region (Assam, Arunachal Pradesh, Manipur, Meghalaya, Mizoram, Nagaland, Sikkim and Tripura states) 
were computed using population weighted average of the rates from nine population-based cancer registries (29% coverage around 2011). These 
rates were applied to the corresponding 2018 population. 
2. Remaining urban population: rates from seven cancer registries (Bangalore, Bhopal, Chennai, Mumbai, Delhi, Nagpur, Pune) (15% coverage of 
urban population) for the period 2003-2012 were projected to 2018 and applied to the 2018 urban population. These seven registries were 
supplemented by three cancer registries (Aurangabad, Kollam and Trivandrum) when projection cannot be performed (use of the most recent rates). 
3. Remaining rural population: rates from six cancer registries (Ahmedabad, Ambilikkai, Barshi, Mansa, Sangrur and Wardha) (1% coverage of rural 
population) were applied to the 2018 rural population. The overall incidence estimate for India for 2018 is the sum of the three estimates.8  
 
GBD estimates come from: Global Burden of Disease Study 2016. Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and 
Disability-Adjusted Life Years 1990-2016.10,11 The estimation of cancer incidence was driven by registry data from India. Estimates were produced 
initially for each state. For states with at least one population-based cancer registry, the incidence data were transformed to mortality by multiplying 
incidence data with an independently modelled urban or rural mortality-incidence (MI) ratio for the respective states. Authors computed the 
population-weighted mean of these state estimates as the estimate for India. Authors based age-standardized rates on the GBD global reference 
population. 95% uncertainty intervals (UIs) were based on 1000 runs of the models for each quantity of interest, with the mean considered as the 
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Table 2: Context, coverage, processes and cancer cases in six population-based cancer registries in India 












Registry Characteristics     
 Year created 1963 1987 1994 2003 2013 2013 







Civil Hospital  PGIMER, 
School of Public 
Health  
Civil Hospital and 
Homi Bhabha 
Cancer Hospital  
 Catchment area Greater Mumbai  Barshi  Thiruvanthapuram 
district 
Mizoram state Chandigarh 
(Union 
Territory)  
Sangrur district  
 Population covered 25.2 million 1.5 million  3.3 million 1.1 million 1.1 million  1.7 million  
 % Rural  0% 100% 46.34% 47.89% 2.75% 69% 
 SqKm covered 603 sq.km 3713 sq.km 2129 sq.km 21,081 sq.km 114 sq.km  3625 sq.km 
 Population density 
(people per sq.km) 
19,652 Unknown  1509 52 9258 457 
Registry Cancer Outcomes in most recent report     
 Most recent report 2 year report; 
2013-14 
3 year report;  
2012-2014  
3 year report;  
2012-14  
5 year report; 
2010-14  
1 year report; 
2014  
1 year report; 
2014  
 Number of cases 
(Calendar years of data)  
27623 (2013-
14) 
929 (2012-14) 15,694 (2012-14) 7,535 (2010-
14) 
840 (2014) 879 (2014) 
 Average number of cases 
per year 
13,756 ~309 ~5231  ~1552 870 879 
 AAR (Female) 119.7 60.4 132.5 164.3 102.6 57.6  
 AAR (Male) 111 53.9 122 210.5 96.9 47.8 
 Top 3 leading sites and 






organs (18.3%)  




3. Ovary (4.6%) 
1. Breast (28.8%) 
2. Thyroid (10.4%) 










2. Cervix Uteri 
(8.2%) 
3. Ovary (7.7%)  
1. Breast (23.8%) 




 Top 3 leading sites and 
% of cases (Male) 





1. Mouth (8.6%) 
2. Oesophagus 
(7.7%) 
3. Liver (6.2%) 
1. Lung (13.0%) 
2. Oral Cavity 
(10.5%) 














2. Mouth (5.6%) 
3. Tongue (5.6%)  
Data and Reporting      
 Approximate number of 
institutional data sources 
50 56 75 45 33 29 





house visits  
  
 Occasional phone 
calls and house 
visits 
 Routine 











 Routine village 
and house visits  
 Verbal autopsy  
  











 Ever sent data to CI5 Yes Yes Yes Yes N/A** N/A** 
 Data included in 
GLOBOCAN 2018 
Yes Yes Yes Yes No Yes 
 Data publicly available No No No No No No 
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Cancer Society of 
Finland 
NCRP TMC TMC 
  Technical assistance NCRP NCRP 
TMC 
IARC  




*Reproductive organs includes ovary, cervix, corpus uteri  
**N/A as registry created after most recent CI5 (2008-12) 
Sources: Interviews, Registry Reports (see Supplementary Materials), GLOBOCAN 2018, CI5, India Census 2011.  
Definitions: NCRP=National Cancer Registry Program; TMC=Tata Memorial Center; IARC=International Agency for Research on Cancer; 
PGIMER=Post Graduate Institute of Medical Education and Research, Chandigarh. Cases per year either estimated in the reports or calculated. 
 
Table 3: Sociodemographic information collected and reported by six population-based 















Collected Reported Collected Reported Collected Reported Collected Reported Collected Reported Collected Reported 
Age + + + + + + + + + + + + 
Sex + + + + + + + + + + + + 
Geography  + + + No + No + No + + + + 
Income No No No No No No No No + No + No 
Occupation No No No No No No No No + No + No 
Education  + + + No + No + No + No + No 
Marital status + + + No + No + No No No No No 
Mother tongue  + + + No + No + No + No + No 




No No No No No No No No No No No No 
Caste No No No No No No No No No No No No 
Table shows the sociodemographic variables collected and reported by six PBCRs.  
 
Collected refers to the information collected from patients by the PBCR and is based on the data collection form used for incidence data. 
Reported refers to the information available in the most recent PBCR report (or from the NCRP report) and whether cancer incidence or case 
counts are disaggregated by the sociodemographic variables listed. Geography refers to incidence estimates disaggregated by village, district, 
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Table 4: Types of peer-reviewed research using data from population-based cancer registries in India presenting cancer inequities 
Category  Definition  
Total number 
of records 
Records reporting cancer outcomes disaggregated by sociodemographic variables 
Total* By sociodemographic variable 
















SC, ST  
Caste 
Cancer surveillance  
Studies reporting the epidemiology of cancer, 
incidence, survival, DALYs, mortality  
109 47% 45 41% 10 2 0 16 15 2 28 2 0 
Cancer surveillance: 
Time Trends  
Studies estimating trends in cancer incidence, or 
cumulative risk over time 
50 22% 8 16% 5 0 0 0 0 0 3 0 0 
Projections 
Studies estimating cancer projections using PBCR 
data  
9 4% 1 11% 1 0 0 0 0 0 0 0 0 
Case-control, cohort, 
associational studies  
Case-control or cohort studies using PBCR data, 
studies on the association between behaviors and 
cancer outcomes 
20 9% 16 80% 3 7 8 12 5 4 13 0 0 
Studies about 
PBCRs in India 
Studies on data quality, methods for cancer 
registration, studies on the state of registration in 
India 
38 17%  
Cost  
Studies on the cost of cancer registration in India, or 
on the economic cost of cancer  
4 2%  
 Total 230 100% 70                     
Table shows the results of a literature search for articles using PBCR data, or articles about PBCRs in India. For articles utilizing PBCR data, the table shows which articles reported cancer outcomes 
disaggregated by sociodemographic variables.  
 
A total of 1290 records were screened after duplicates were removed. 230 records were identified to fit the inclusion criteria. The full text and tables of 188 articles which utilized PBCR data were searched 
for estimates of cancer outcomes disaggregated by sociodemographic variables.  
 
*Total n and % of articles reporting disaggregated estimates of cancer is based on a full text search. If the full text was not available, we relied on the abstract (n=7).  
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Table 5: Challenges in data collection faced by six population-based cancer registries in 
India 
Theme  Illustrative examples  
Cooperation of 
data sources  
"Not all [sources] cooperate the same way and there are differences in the facilities and staff. We need to phone patients 
to address the [data] gaps, but even getting their contact information can be hard." (Mizoram) 
 
"This is a big challenge for registries in metros: urban registries don’t go house to house or do patient interviews so are 
very reliant on hospital data...we need to convince the hospitals...it’s about personal relations, the staff develop a 
relationship with hospitals" (Mumbai) 
 
"Most hospitals have electronic data but don’t give us a copy...we can see it on the screen and fill in our forms...this makes 
it easier to complete." (Mumbai) 
 
“It is very hard to collect data from the hospitals…they are congested, sometimes we don’t get a seat and have to sit on 
the floor...we adjust” (Thiruvanthapuram) 
 
“Hospitals say ‘why should we give you our patients’ records?’...or they say they don’t have time or call us early in the 
morning. Some hospitals say to come on a Sunday because the hospital is closed and they are off that day and can take out 
all the records and not interrupt their work to give us the records. We just go on Sunday...the main thing we have learned 
is not to stop until we have the record...not to get angry, to go the next day if they say so...they can say no once or twice, 
but will they say no ten times? We just have to keep trying.” (Barshi) 
Abstraction of 
data in medical 
records   
“We need to go through all the cases at the general hospitals which takes longer. For example, we go through 200 forms 
to get 10 cases” (Mumbai) 
 
“100,000 patients report [to the hospital] and there are 100,000 files to go through to see if they are from 
Thiruvanthapuram” (Thiruvanthapuram) 
 
“We need to go to the medical records department and to pathology to get complete information. Pathology does not have 
the address but we use pathology [reports] to confirm cases.” (Thiruvanthapuram) 
 
"Poor medical records are a challenge, some institutes are not keeping proper records, or institutes sometimes don’t want 
to give all the records. But we can get records from the villages." (Barshi) 
 
"In the government medical college there is no online system, there is a huge register for histopathology and 
cytopathology where they have reported all the patients...we have to identify whether it is malignant or not...data are 
month-wise and there are 300-400 reports in the register...they are manual registers...our staff has to sit with the 
histopathology and cytopathology [registers] which are different and abstract the data into our forms…we have to cross 
verify the registration number to see if it is a Sangrur area. It is a very challenging tough job." (Sangrur)  
Address 
verification  
“There are challenges with the address. We need the proper address and often people will just put the city name or the 
name of a town. Let’s say someone come from Serchhip [a district in Mizoram] to Aizawl. They will put Aizawl as they are 
staying with their family here, and we have to confirm this.” (Mizoram) 
Cancer stigma  
“Everyone thinks cancer is fatal.... there have been cases where people’s break down, faint or cry." (Mizoram) 
 
"People really do not want to go to hospital” (Barshi) 
 
"Suppose one patient gets bad treatment in the hospital...then we are [the ones] going house to house and we have to deal 
with this. That is the main problem. If doctors and nurses are badly behaved, we are suffering, and the data is hard to get. 
If you go right after the incident 10-15 days, it is worse." (Barshi) 
 
"They [patients] are very fearful...it’s a very dreaded thing...sometimes even the relatives don’t want it to be disclosed to 
the patient. They won’t take the name of cancer...they ask us not tell the patient." (Sangrur) 
 
“They ask is to okay if they stay in a family together, eat together, does it spread through touch. And once there is a 





"We contact the family, but the family discards or burns the information as they don’t want to be reminded [of the death]. 
It’s hard to get information on the primary site and morphology" (Mizoram) 
 
"We need to go to the Panchayat [local government] to figure out the home address and then do a home visit. In these 
records, sometimes cause of death is listed as 'illness or old age'. There is only aggregated data available at the Taluka 
level [administrative unit], so we also need to go to Panchayat." (Barshi) 
 
“In the villages, when there is a death, they burn all the documents. People don’t want forms lying around that say 
‘cancer’ due to the stigma. So, we do a verbal autopsy and meet the relatives…without forms and medical records it is 
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Migration  
"Many people still leave the state for cancer. We share the data with other registries but it’s hard to get full information. 
For example, sometimes there is no biopsy report and people [families and patients] don’t always keep papers." 
(Mizoram) 
 
"The furthest source is 400km away in Mumbai. For earning purposes, a lot of people go to Mumbai. If a parent has 
cancer they might go to Mumbai where their son is." (Barshi) 
 
"We go through the files, there is a 4-5 page form with the death certificate. If there is any mention of cancer or tumor, we 
collect this information even if the person is not resident in Mumbai. People come to Mumbai to die” (Mumbai) 
 
 
Table 6: Recommendations for new registries and to improve cancer registration 
Theme Recommendations and Implications for new population-based cancer registries  
Sociodemographic 
data  
 Collect individual level sociodemographic information based on patient interviews or medical records, and 
conduct quality checks on this information  
 Explore address geocoding  
Rural registries  
 Work closely with the village level health system and local government  
 Collect data on cancer cases from hospitals, labs, crematoriums, burial grounds, death registries  
 Link cancer registration to cancer screening  
 Train health workers to recognize cancer symptoms and refer patients  
 Train registration staff on how to conduct education about cancer and stigma reduction  
Design of PBCR  
 Start slowly with key variables and develop institutional practices to collect data and ensure quality  
 Develop a HBCR and/or PBCR alongside the development of cancer hospitals   
 Link the data systems of HBCRs with PBCRs 
 Conduct training for doctors and staff in key data sources on cancer registration  
 Build in checks of data quality  
 Include several questions to confirm address and residence   
Approaches to 
collecting data  
 Develop strong institutional and personal relationships with data sources  
 Persevere while getting data  
 Develop processes to share data with other cancer registries to capture migration 
Data linking  
 Consider integrated cancer and NCD registries 
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